RESUMO
We explore the effects of group size on the direct reproductive success of subordinate helpers in eusocial animals where only a single, dominant individual reproduces at one time. Helpers can reproduce directly if they inherit dominance, but when dominance is age based, an individual born into a larger group has a longer wait to inherit. We show that this disincentive to help can potentially be offset by increased productivity, increased life span, and insurance-based benefits for helpers if they survive to inherit dominance in larger groups. We analyze a field experiment in which group size was manipulated in the hover wasp Liostenogaster flavolineata. Productivity increased linearly with group size, larger groups were less likely to fail, and dominants in larger groups may have lived longer. Combined with the probability of inheriting dominance, these effects led overall to a negative correlation between group size and expected direct fitness, mainly because group size decreased during our study period, so that helpers could not expect to inherit as large a group as they started queuing in. Our analysis suggests that the relationship between group size and productivity plays a central role in determining the fitness consequences of helping.
RESUMO
Recent explanations for the evolution of eusociality, focusing more on costs and benefits than relatedness, are largely untested. We validate one such model by showing that helpers in foundress groups of the paper wasp Polistes dominulus benefit from an insurance-based mechanism known as Assured Fitness Returns (AFRs). Experimental helper removals left remaining group members with more offspring than they would normally rear. Reduced groups succeeded in preserving the dead helpers' investment by rearing these extra offspring, even when helper removals occurred long before worker emergence. While helpers clearly gained from AFRs, offspring of lone foundresses failed after foundress death, so that AFRs represent a true advantage for helpers. Smaller, less valuable offspring were probably sacrificed to feed larger offspring, but reduced groups did not preferentially attract joiners or increase their foraging effort to compensate for their smaller workforce. We failed to detect a second insurance-based advantage, Survivorship Insurance, in which larger groups are less likely to fail than smaller groups. We suggest that through their use of small offspring as a food store to cope with temporary shortages, wasps may be less susceptible than vertebrates to offspring failure following the death of group members.
Assuntos
Facilitação Social , Vespas/fisiologia , Animais , Evolução Biológica , Feminino , Modelos Biológicos , Dinâmica Populacional , Seleção Genética , EspanhaRESUMO
PURPOSE: A definition for progression of ovarian cancer has been proposed based on either a confirmed doubling of CA-125 levels from the upper limit of normal or from the nadir level if levels are persistently elevated. Retrospectively, we determined whether the use of this CA-125 definition in a randomized trial would have shown the same magnitude of difference between the treatment arms as was shown when the standard progression definition was used. PATIENTS AND METHODS: A retrospective analysis was performed on 680 patients in the Taxol Intergroup Trial with advanced epithelial ovarian carcinoma, of whom 628 were assessable according to CA-125. The date of progression according to clinical or radiologic criteria was compared with the date of progression according to CA-125. RESULTS: Of the 628 patients assessable for both definitions, 556 clinical or radiologic progressions were determined compared with 389 according to the CA-125 definition. There was a highly significant difference in the hazard of progression between the paclitaxel and cisplatin arm (TP) compared with the cyclophosphamide and cisplatin arm (CP) when either standard or CA-125 criteria were used to define progression (standard, P = .002; CA-125, P = .011). The hazard ratio of TP/CP over time was similar when comparing the different methods of defining progression. CONCLUSION: The results of this analysis show that the magnitude of the therapeutic benefit was similar whether CA-125 or standard criteria were used to define progression.